Wenru Tang

1.6k total citations
93 papers, 1.2k citations indexed

About

Wenru Tang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wenru Tang has authored 93 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 29 papers in Oncology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wenru Tang's work include Cancer-related Molecular Pathways (18 papers), Ferroptosis and cancer prognosis (13 papers) and Epigenetics and DNA Methylation (13 papers). Wenru Tang is often cited by papers focused on Cancer-related Molecular Pathways (18 papers), Ferroptosis and cancer prognosis (13 papers) and Epigenetics and DNA Methylation (13 papers). Wenru Tang collaborates with scholars based in China, Poland and United States. Wenru Tang's co-authors include Ying Luo, Xiaoming Wu, Chunjie Xiao, Shuting Jia, Ying Luo, Jin Chen, Haijing Yu, Ying Chan, Miaomiao Sheng and Li He and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Gene.

In The Last Decade

Wenru Tang

90 papers receiving 1.1k citations

Peers

Wenru Tang
Ningzheng Dong China
Kwi Hye Koh United States
Rong Bu Saudi Arabia
Hemang Parikh United States
Dil Afroze India
Ashwini L. Chand Australia
Seiya Sato Japan
Ryan Kopp United States
Ningzheng Dong China
Wenru Tang
Citations per year, relative to Wenru Tang Wenru Tang (= 1×) peers Ningzheng Dong

Countries citing papers authored by Wenru Tang

Since Specialization
Citations

This map shows the geographic impact of Wenru Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenru Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenru Tang more than expected).

Fields of papers citing papers by Wenru Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenru Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenru Tang. The network helps show where Wenru Tang may publish in the future.

Co-authorship network of co-authors of Wenru Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenru Tang. A scholar is included among the top collaborators of Wenru Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenru Tang. Wenru Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qi, Qi, et al.. (2024). Identification of potential drug targets for allergic diseases from a genetic perspective: A mendelian randomization study. Clinical and Translational Allergy. 14(4). e12350–e12350. 2 indexed citations
2.
Zhou, Xuhong, et al.. (2023). Widely targeted metabolomics reveals the antioxidant and anticancer activities of different colors of Dianthus caryophyllus. Frontiers in Nutrition. 10. 1166375–1166375. 6 indexed citations
3.
Li, Huimin, Xiaoling Zhang, Zhengwei Luo, et al.. (2023). Application of Novel Transcription Factor Machine Learning Model and Targeted Drug Combination Therapy Strategy in Triple Negative Breast Cancer. International Journal of Molecular Sciences. 24(17). 13497–13497. 4 indexed citations
4.
Chen, Yongzhi, et al.. (2023). Single-cell and bulk RNA-sequencing analysis to predict the role and clinical value of CD36 in lung squamous cell carcinoma. Heliyon. 9(11). e22201–e22201. 2 indexed citations
5.
Li, Ming, et al.. (2022). Clinical significance and mechanism of long noncoding RNA HAGLROS in triple negative breast cancer. Pathology - Research and Practice. 231. 153810–153810. 6 indexed citations
6.
Chan, Ying, et al.. (2016). Influence of TP53 Codon 72 Polymorphism Alone or in Combination with HDM2 SNP309 on Human Infertility and IVF Outcome. PLoS ONE. 11(11). e0167147–e0167147. 11 indexed citations
7.
Zhou, Ruoyu, Chuanyu Wei, Jing Liu, Ying Luo, & Wenru Tang. (2015). The prognostic value of p53 expression for patients with cervical cancer: a meta analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 195. 210–213. 19 indexed citations
8.
Wu, Wei, et al.. (2015). Association of RASSF1A Promoter Methylation with Lung Cancer Risk: a Meta-analysis. Asian Pacific Journal of Cancer Prevention. 15(23). 10325–10328. 10 indexed citations
9.
10.
Yang, Kunxian, et al.. (2014). The Prognosis of MGMT Promoter Methylation in Glioblastoma Patients of Different Race: A Meta-analysis. Neurochemical Research. 39(12). 2277–2287. 14 indexed citations
11.
Zhao, Xilong, et al.. (2013). Association of p53 Arg72Pro Polymorphism with Esophageal Cancer: A Meta-Analysis Based on 14 Case-Control Studies. Genetic Testing and Molecular Biomarkers. 17(10). 721–726. 14 indexed citations
12.
Wu, Xiaoming, Xiaohuan Wang, Ying Chan, et al.. (2013). Folate metabolism gene polymorphisms MTHFR C677T and A1298C and risk for Down syndrome offspring: a meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 167(2). 154–159. 37 indexed citations
13.
Xu, Lin, Ying Chan, Xiaoming Wu, et al.. (2012). p53 codon 72 polymorphism and endometriosis: a meta-analysis. Archives of Gynecology and Obstetrics. 285(6). 1657–1661. 12 indexed citations
14.
Zhang, Xiufeng, et al.. (2012). Association Between the CTLA-4 +49A/G Polymorphism and Type 1 Diabetes: A Meta-Analysis. Genetic Testing and Molecular Biomarkers. 16(11). 1336–1342. 7 indexed citations
15.
Tang, Wenru, et al.. (2012). The Gain of Function of p53 Mutant p53S in Promoting Tumorigenesis by Cross-talking with H-RasV12. International Journal of Biological Sciences. 8(5). 596–605. 19 indexed citations
16.
Hou, Jing, et al.. (2012). The cooperation between <I>p53</I> and <I>Ras</I> in tumori-genesis. Hereditas (Beijing). 34(12). 1513–5121. 1 indexed citations
17.
Tang, Wenru, et al.. (2011). Cryopreservation of epididymal sperm in tree shrews (Tupaia belangeri). Theriogenology. 76(1). 39–46. 6 indexed citations
18.
Zhang, Xiufeng, Wenru Tang, & Ying Luo. (2009). Aging or tumor: the crosstalk between telomerase and <I>p53</I>. Hereditas (Beijing). 31(5). 451–456. 1 indexed citations
19.
Wang, Bo, et al.. (2006). Sequencing‐based analysis of the HLA‐DPB1 polymorphism in Nu ethnic group of south‐west China. International Journal of Immunogenetics. 33(6). 397–400. 5 indexed citations
20.
He, Li, et al.. (2006). The Relationship between CYP17 –34T/C Polymorphism and Acne in Chinese Subjects Revealed by Sequencing. Dermatology. 212(4). 338–342. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ningzheng Dong Breakdown of academic impact, for papers by Kwi Hye Koh Breakdown of academic impact, for papers by Rong Bu Breakdown of academic impact, for papers by Hemang Parikh Breakdown of academic impact, for papers by Dil Afroze Breakdown of academic impact, for papers by Ashwini L. Chand Breakdown of academic impact, for papers by Seiya Sato Breakdown of academic impact, for papers by Ryan Kopp
Rankless by CCL
2026